| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Global cancer statistics.
|
CA Cancer J Clin
|
2011
|
185.92
|
|
2
|
Quality of life and satisfaction with outcome among prostate-cancer survivors.
|
N Engl J Med
|
2008
|
18.60
|
|
3
|
Long-term functional outcomes after treatment for localized prostate cancer.
|
N Engl J Med
|
2013
|
7.95
|
|
4
|
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
|
N Engl J Med
|
2016
|
5.71
|
|
5
|
Cancer Statistics, 2017.
|
CA Cancer J Clin
|
2017
|
4.77
|
|
6
|
Cancer treatment and survivorship statistics, 2016.
|
CA Cancer J Clin
|
2016
|
2.93
|
|
7
|
Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.
|
Int J Radiat Oncol Biol Phys
|
2007
|
2.55
|
|
8
|
Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.
|
Med Care
|
1995
|
2.55
|
|
9
|
Population-Based Assessment of Determining Treatments for Prostate Cancer.
|
JAMA Oncol
|
2015
|
2.46
|
|
10
|
Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function.
|
J Clin Oncol
|
2009
|
2.40
|
|
11
|
Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.60
|
|
12
|
Proton beam and prostate cancer: An evolving debate.
|
Rep Pract Oncol Radiother
|
2013
|
1.48
|
|
13
|
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer.
|
Int J Radiat Oncol Biol Phys
|
2016
|
1.40
|
|
14
|
Lifetime economic burden of prostate cancer.
|
BMC Health Serv Res
|
2011
|
0.96
|
|
15
|
Proton radiobiology.
|
Cancers (Basel)
|
2015
|
0.89
|
|
16
|
Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2014
|
0.84
|
|
17
|
Deficiency in homologous recombination renders Mammalian cells more sensitive to proton versus photon irradiation.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.83
|
|
18
|
Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate Cancer.
|
Eur Urol
|
2016
|
0.79
|
|
19
|
Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts.
|
Rev Urol
|
2014
|
0.75
|
|
20
|
Deciphering the Acute Cellular Phosphoproteome Response to Irradiation with X-rays, Protons and Carbon Ions.
|
Mol Cell Proteomics
|
2017
|
0.75
|
|
21
|
Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured Patients.
|
Int J Radiat Oncol Biol Phys
|
2017
|
0.75
|
|
22
|
Comprehensive track-structure based evaluation of DNA damage by light ions from radiotherapy-relevant energies down to stopping.
|
Sci Rep
|
2017
|
0.75
|